Searching News Database: head and neck
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 6 Feb 2026
Insilico Medicine Appoints Halle Zhang, PhD (Med), as Vice President, Clinical Development - Oncology
Insilico Medicine Appoints Halle Zhang, PhD (Med), as Vice President, Clinical Development - Oncology
HSMN NewsFeed - 8 Jul 2025
Soligenix Corporate Update Letter - Key Highlights and Upcoming Milestones
Soligenix Corporate Update Letter - Key Highlights and Upcoming Milestones
HSMN NewsFeed - 18 Aug 2023
FDA grants priority review for full approval of TARPEYO for the treatment of IgA Nephropathy
FDA grants priority review for full approval of TARPEYO for the treatment of IgA Nephropathy
HSMN NewsFeed - 22 Jun 2022
Angiex Strengthens its Leadership Team with the Appointment of Marty J. Duvall as Chief Executive Officer
Angiex Strengthens its Leadership Team with the Appointment of Marty J. Duvall as Chief Executive Officer
HSMN NewsFeed - 3 Nov 2020
Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer
Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer
HSMN NewsFeed - 28 May 2020
Smith & Nephew announces US launch of the revolutionary Tula(R) System for placement of ear tubes
Smith & Nephew announces US launch of the revolutionary Tula(R) System for placement of ear tubes
HSMN NewsFeed - 15 May 2020
Soligenix Announces Recent Accomplishments And First Quarter 2020 Financial Results
Soligenix Announces Recent Accomplishments And First Quarter 2020 Financial Results
HSMN NewsFeed - 13 Mar 2020
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
HSMN NewsFeed - 30 Dec 2019
Lilly Opens Phase 3 Clinical Trial in RET-Mutant Medullary Thyroid Cancer
Lilly Opens Phase 3 Clinical Trial in RET-Mutant Medullary Thyroid Cancer
HSMN NewsFeed - 16 Sep 2019
Soligenix Appoints Daniel P. Ring as Vice President of Business Development and Strategic Planning
Soligenix Appoints Daniel P. Ring as Vice President of Business Development and Strategic Planning
HSMN NewsFeed - 8 Jul 2019
Soligenix Announces Appointment of Diane L. Parks to its Board of Directors
Soligenix Announces Appointment of Diane L. Parks to its Board of Directors
HSMN NewsFeed - 31 May 2019
Iovance Biotherapeutics Expands Partnership with WuXi Advanced Therapies Business
Iovance Biotherapeutics Expands Partnership with WuXi Advanced Therapies Business
HSMN NewsFeed - 30 Apr 2019
South Africa Hospital Delivers HDR Brachytherapy Cancer Treatments with Varian Bravos Afterloader System
South Africa Hospital Delivers HDR Brachytherapy Cancer Treatments with Varian Bravos Afterloader System
HSMN NewsFeed - 19 Apr 2019
CIVCO Radiotherapy Presents Proton Head & Neck Immobilization Solution at ESTRO 38
CIVCO Radiotherapy Presents Proton Head & Neck Immobilization Solution at ESTRO 38
HSMN NewsFeed - 1 Apr 2019
Artios Pharma Announces Appointment of Dr. Ian Smith as Chief Medical Officer
Artios Pharma Announces Appointment of Dr. Ian Smith as Chief Medical Officer
HSMN NewsFeed - 15 Oct 2018
CIVCO Radiotherapy Announces FDA 510k Clearance and CE Mark of their Solstice SRS Immobilization System
CIVCO Radiotherapy Announces FDA 510k Clearance and CE Mark of their Solstice SRS Immobilization System
HSMN NewsFeed - 4 Oct 2018
HCG is First in India to Treat Cancer Patients Using the Accuray Radixact(R) System
HCG is First in India to Treat Cancer Patients Using the Accuray Radixact(R) System
HSMN NewsFeed - 24 Sep 2018
Cumberland Pharmaceuticals Announces Senior Music Industry Executive Joins Its Board Of Directors
Cumberland Pharmaceuticals Announces Senior Music Industry Executive Joins Its Board Of Directors
HSMN NewsFeed - 7 Sep 2018
Optim Partners with 21st Century Oncology as the Preferred Vendor for Head and Neck Cancer Endoscopy
Optim Partners with 21st Century Oncology as the Preferred Vendor for Head and Neck Cancer Endoscopy
HSMN NewsFeed - 5 Sep 2018
Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure Cancer
Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure Cancer
HSMN NewsFeed - 21 Aug 2018
Alpha Tau's High-Precision Cancer Radiotherapy Receives Radioactive-Safety Approval in the United States
Alpha Tau's High-Precision Cancer Radiotherapy Receives Radioactive-Safety Approval in the United States
HSMN NewsFeed - 25 Jul 2018
Addenbrooke's Hospital is First in the UK to Treat Cancer Patients with Accuray Radixact(R) System
Addenbrooke's Hospital is First in the UK to Treat Cancer Patients with Accuray Radixact(R) System
HSMN NewsFeed - 24 Jul 2018
Soligenix Announces Appointment of Mark Pearson to its Board of Directors
Soligenix Announces Appointment of Mark Pearson to its Board of Directors
HSMN NewsFeed - 25 Jun 2018
Radiation oncologists urge Congress to protect patient access to cancer care
Radiation oncologists urge Congress to protect patient access to cancer care
HSMN NewsFeed - 21 Jun 2018
Accuray Receives AERB Approval for Sale and Supply of its Radixact(R) X9 System in India
Accuray Receives AERB Approval for Sale and Supply of its Radixact(R) X9 System in India
HSMN NewsFeed - 8 Jun 2018
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
HSMN NewsFeed - 25 Sep 2017
Cumberland Pharmaceuticals Launches Promotion of Totect(R) in The U.S. for Emergency Oncology Intervention
Cumberland Pharmaceuticals Launches Promotion of Totect(R) in The U.S. for Emergency Oncology Intervention
HSMN NewsFeed - 21 Sep 2017
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
HSMN NewsFeed - 28 Jul 2017
Bracco Diagnostics Inc. Receives U.S. FDA Approval for VARIBAR(R) NECTAR (barium sulfate) Oral Suspension
Bracco Diagnostics Inc. Receives U.S. FDA Approval for VARIBAR(R) NECTAR (barium sulfate) Oral Suspension
HSMN NewsFeed - 21 Jul 2017
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
HSMN NewsFeed - 20 Jul 2017
New Data Show TomoTherapy(R) System Superior to RapidArc in Achieving Local Control of Head and Neck Cancers
New Data Show TomoTherapy(R) System Superior to RapidArc in Achieving Local Control of Head and Neck Cancers
HSMN NewsFeed - 17 Jul 2017
Phoenix Molecular Designs Appoints Leading Oncology Expert Dr. Gerrit Los as Chief Scientific Officer
Phoenix Molecular Designs Appoints Leading Oncology Expert Dr. Gerrit Los as Chief Scientific Officer
HSMN NewsFeed - 13 Jul 2017
American Society for Radiation Oncology Updates Insurance Coverage Recommendations for Proton Therapy
American Society for Radiation Oncology Updates Insurance Coverage Recommendations for Proton Therapy
HSMN NewsFeed - 11 Jul 2017
Neuro Spinal Hospital in Dubai to Acquire Accuray CyberKnife(R) and Radixact(TM) Systems
Neuro Spinal Hospital in Dubai to Acquire Accuray CyberKnife(R) and Radixact(TM) Systems
HSMN NewsFeed - 7 Jul 2017
IsoRay Announces Appointment of Mark Austin as Controller, Principal Accounting and Financial Officer
IsoRay Announces Appointment of Mark Austin as Controller, Principal Accounting and Financial Officer
HSMN NewsFeed - 20 Jun 2017
IUCT Oncopole Advances Cancer Care in France with the New Accuray Radixact(TM) System
IUCT Oncopole Advances Cancer Care in France with the New Accuray Radixact(TM) System
HSMN NewsFeed - 30 May 2017
Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration
Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration
HSMN NewsFeed - 28 Apr 2017
Sorrento Therapeutics Announces Closing of its Acquisition of Virttu Biologics
Sorrento Therapeutics Announces Closing of its Acquisition of Virttu Biologics
HSMN NewsFeed - 20 Jan 2017
Bristol-Myers Squibb Provides Regulatory Update in First-line Lung Cancer
Bristol-Myers Squibb Provides Regulatory Update in First-line Lung Cancer
HSMN NewsFeed - 27 Sep 2016
IBA's Proton Therapy Community Achieves the Next Big Milestone With 50,000 Cancer Patients Treated
IBA's Proton Therapy Community Achieves the Next Big Milestone With 50,000 Cancer Patients Treated
HSMN NewsFeed - 27 Sep 2016
IsoRay, Inc. Enters Into Agreement to Settle Class Action Shareholder Litigation
IsoRay, Inc. Enters Into Agreement to Settle Class Action Shareholder Litigation
HSMN NewsFeed - 17 May 2016
Leeds St James Acquires Eight Elekta Linear Accelerators for Advanced Cancer Treatment
Leeds St James Acquires Eight Elekta Linear Accelerators for Advanced Cancer Treatment
HSMN NewsFeed - 6 Apr 2016
Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Patients
Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Patients
HSMN NewsFeed - 4 Mar 2016
Acumed Releases Slide-Loc(TM) Anatomic Radial Head System, Featuring Unique Side-Loading Design
Acumed Releases Slide-Loc(TM) Anatomic Radial Head System, Featuring Unique Side-Loading Design
HSMN NewsFeed - 23 Jan 2016
Cellceutix Releases Data Used in Receiving FDA Orphan Drug Designation of Kevetrin for Pancreatic Cancer
Cellceutix Releases Data Used in Receiving FDA Orphan Drug Designation of Kevetrin for Pancreatic Cancer
HSMN NewsFeed - 24 Dec 2015
Eagle Pharmaceuticals Announces FDA Approval of Docetaxel Injection, Non-Alcohol Formula
Eagle Pharmaceuticals Announces FDA Approval of Docetaxel Injection, Non-Alcohol Formula
HSMN NewsFeed - 16 Dec 2015
BIND Therapeutics Appoints Jonathan Yingling, Ph.D., as Chief Scientific Officer
BIND Therapeutics Appoints Jonathan Yingling, Ph.D., as Chief Scientific Officer
HSMN NewsFeed - 19 Oct 2015
Virttu Biologics Announces Appointment Of Deirdre Y. Gillespie As Chief Executive Officer
Virttu Biologics Announces Appointment Of Deirdre Y. Gillespie As Chief Executive Officer
HSMN NewsFeed - 16 Oct 2015
Qfix Announces Launch of New Portrait(TM) S-Frame Mask for Head and Neck Radiotherapy Treatment
Qfix Announces Launch of New Portrait(TM) S-Frame Mask for Head and Neck Radiotherapy Treatment
HSMN NewsFeed - 15 Oct 2015
Teikoku Pharma USA and Eagle Pharmaceuticals Enter into License Agreement for Docetaxel, Non-Alcohol Formula
Teikoku Pharma USA and Eagle Pharmaceuticals Enter into License Agreement for Docetaxel, Non-Alcohol Formula
HSMN NewsFeed - 12 Oct 2015
Seven US Medical Centers to Acquire Elekta's New Leksell Gamma Knife Icon Brain Radiosurgery System
Seven US Medical Centers to Acquire Elekta's New Leksell Gamma Knife Icon Brain Radiosurgery System
HSMN NewsFeed - 5 Aug 2015
Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer
Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer
HSMN NewsFeed - 23 Jul 2015
Medrobotics(R) Corporation Receives FDA Clearance to Market Flex(R) Robotic System
Medrobotics(R) Corporation Receives FDA Clearance to Market Flex(R) Robotic System
HSMN NewsFeed - 14 Jul 2015
New TomoTherapy(R) System Data Presented at Leading Scientific Industry Meeting
New TomoTherapy(R) System Data Presented at Leading Scientific Industry Meeting
HSMN NewsFeed - 6 Jul 2015
OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development
OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development
HSMN NewsFeed - 17 Dec 2014
Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology
Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology
HSMN NewsFeed - 27 Mar 2014
Accuray Incorporated's CyberKnife(R) M6(TM) System Receives Shonin Approval
Accuray Incorporated's CyberKnife(R) M6(TM) System Receives Shonin Approval
HSMN NewsFeed - 19 Mar 2014
IsoRay Announces World's First Pediatric Cesium-131 Seeded Mesh Treatment for Metastatic Wilms Tumor
IsoRay Announces World's First Pediatric Cesium-131 Seeded Mesh Treatment for Metastatic Wilms Tumor
HSMN NewsFeed - 7 Jan 2014
Navidea Biopharmaceuticals Expands Lymphoseek(R) Global Commercialization Efforts
Navidea Biopharmaceuticals Expands Lymphoseek(R) Global Commercialization Efforts
HSMN NewsFeed - 20 Dec 2013
Cellceutix Files Orphan Drug Designation Application for Brilacidin for Oral Mucositis with US FDA
Cellceutix Files Orphan Drug Designation Application for Brilacidin for Oral Mucositis with US FDA
HSMN NewsFeed - 3 Oct 2013
Soligenix Appoints Oreola Donini, PhD, as Vice President of Preclinical Research and Development
Soligenix Appoints Oreola Donini, PhD, as Vice President of Preclinical Research and Development
HSMN NewsFeed - 2 Oct 2013
Cook Medical Marks One-Year Anniversary of its Otolaryngology/Head and Neck Surgery Division
Cook Medical Marks One-Year Anniversary of its Otolaryngology/Head and Neck Surgery Division
HSMN NewsFeed - 9 Sep 2013
Kolltan Pharmaceuticals Appoints Carolyn F. Sidor, M.D., as Chief Medical Officer
Kolltan Pharmaceuticals Appoints Carolyn F. Sidor, M.D., as Chief Medical Officer
HSMN NewsFeed - 5 Sep 2013
GSK’s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
GSK’s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
HSMN NewsFeed - 25 Jun 2013
IsoRay Announces a New International Distributor in Australia and New Zealand
IsoRay Announces a New International Distributor in Australia and New Zealand
HSMN NewsFeed - 23 Apr 2013
VentiRx Pharmaceuticals Appoints James Kyle Bryan, M.D. as Chief Medical Officer
VentiRx Pharmaceuticals Appoints James Kyle Bryan, M.D. as Chief Medical Officer
HSMN NewsFeed - 28 Mar 2013
Varian Medical Systems Appoints Deepak "Dee" Khuntia M.D. Vice President of Medical Affairs
Varian Medical Systems Appoints Deepak "Dee" Khuntia M.D. Vice President of Medical Affairs
HSMN NewsFeed - 22 Jan 2013
Clinical Trials Advancing Proton Therapy Research Open at the CDH Proton Center, A ProCure Center
Clinical Trials Advancing Proton Therapy Research Open at the CDH Proton Center, A ProCure Center
HSMN NewsFeed - 28 Nov 2012
Curis Announces Worldwide In-Licensing of IAP Inhibitor GDC-0917 From Genentech
Curis Announces Worldwide In-Licensing of IAP Inhibitor GDC-0917 From Genentech
HSMN NewsFeed - 17 Oct 2012
DelRey ENT Associates Enhances the Care and Comfort of Tonsillectomy Patients with Thermal Fusion Technology
DelRey ENT Associates Enhances the Care and Comfort of Tonsillectomy Patients with Thermal Fusion Technology
HSMN NewsFeed - 2 Oct 2012
Cell Therapeutics OPAXIOTM Receives Orphan Drug Designation for Malignant Brain Cancer from FDA
Cell Therapeutics OPAXIOTM Receives Orphan Drug Designation for Malignant Brain Cancer from FDA
HSMN NewsFeed - 11 Sep 2012
Varian Medical Systems Receives SFDA Clearance to Market the UNIQUE(TM) Radiotherapy System in China
Varian Medical Systems Receives SFDA Clearance to Market the UNIQUE(TM) Radiotherapy System in China
HSMN NewsFeed - 5 Jun 2012
IsoRay Announces World's First Cesium-131 Mesh Treatment for Meningioma Brain Tumors
IsoRay Announces World's First Cesium-131 Mesh Treatment for Meningioma Brain Tumors
HSMN NewsFeed - 9 May 2012
Accuray Unveils Enhanced TomoTherapy Treatment Planning System at ESTRO 31
Accuray Unveils Enhanced TomoTherapy Treatment Planning System at ESTRO 31
HSMN NewsFeed - 12 Apr 2012
New Radiotherapy System Provides More Effective, Safer Cancer Treatment at DMC Huron Valley-Sinai Hospital
New Radiotherapy System Provides More Effective, Safer Cancer Treatment at DMC Huron Valley-Sinai Hospital
HSMN NewsFeed - 28 Mar 2012
Elekta's New Modular Couchtop for Radiation Therapy Adapts to Unique Needs of Individual Patients
Elekta's New Modular Couchtop for Radiation Therapy Adapts to Unique Needs of Individual Patients
HSMN NewsFeed - 8 Mar 2012
The Radiosurgery Society(TM) Completes its First Scientific Meeting as an Independent Society
The Radiosurgery Society(TM) Completes its First Scientific Meeting as an Independent Society
HSMN NewsFeed - 18 Jan 2012
Brain Cancer Patient Receives First TrueBeam STx Treatment in Asia at BGS Global Hospitals in Bangalore
Brain Cancer Patient Receives First TrueBeam STx Treatment in Asia at BGS Global Hospitals in Bangalore
HSMN NewsFeed - 18 Jan 2012
HCG Ahmedabad Becomes First Hospital in India to Deliver Advanced Radiotherapy Treatments Using TrueBeam
HCG Ahmedabad Becomes First Hospital in India to Deliver Advanced Radiotherapy Treatments Using TrueBeam
HSMN NewsFeed - 3 Jan 2012
Novadaq Names MAQUET Cardiovascular Exclusive U.S. Distributor of CO2 Heart Laser Products
Novadaq Names MAQUET Cardiovascular Exclusive U.S. Distributor of CO2 Heart Laser Products
HSMN NewsFeed - 22 Nov 2011
IsoRay Receives Final Regulatory Approval for GliaSite(R) Brain Cancer Treatment
IsoRay Receives Final Regulatory Approval for GliaSite(R) Brain Cancer Treatment
HSMN NewsFeed - 8 Nov 2011
Curis Announces Appointment of Maurizio Voi, M.D. as Chief Medical and Chief Development Officer
Curis Announces Appointment of Maurizio Voi, M.D. as Chief Medical and Chief Development Officer
HSMN NewsFeed - 3 Nov 2011
IsoRay Announces Major International Distribution Agreement for GliaSite(R)
IsoRay Announces Major International Distribution Agreement for GliaSite(R)
HSMN NewsFeed - 31 Oct 2011
World-Renowned Cancer Center to Become All-TrueBeam Clinic in Battle Against Cancer
World-Renowned Cancer Center to Become All-TrueBeam Clinic in Battle Against Cancer
HSMN NewsFeed - 28 Oct 2011
Leading Swedish University Hospital Orders Four TrueBeam Radiotherapy Systems from Varian Medical Systems
Leading Swedish University Hospital Orders Four TrueBeam Radiotherapy Systems from Varian Medical Systems
HSMN NewsFeed - 12 Sep 2011
Entellus Medical Launches PathAssistTM Light SeekerTM to Help ENT Physicians Navigate Frontal Sinus Passages
Entellus Medical Launches PathAssistTM Light SeekerTM to Help ENT Physicians Navigate Frontal Sinus Passages
HSMN NewsFeed - 3 Aug 2011
Al Kindy Hospital in Morocco Carries Out First RapidArc(R) Radiotherapy Treatments in North Africa
Al Kindy Hospital in Morocco Carries Out First RapidArc(R) Radiotherapy Treatments in North Africa
HSMN NewsFeed - 19 Jul 2011
Roche acquires mtm laboratories AG, expanding offering in cervical cancer testing
Roche acquires mtm laboratories AG, expanding offering in cervical cancer testing
HSMN NewsFeed - 12 Jul 2011
IsoRay Announces World's First Cesium-131 Treatment for Lung Cancer Using da Vinci Robotic Surgery System
IsoRay Announces World's First Cesium-131 Treatment for Lung Cancer Using da Vinci Robotic Surgery System
HSMN NewsFeed - 7 Jul 2011
KARL STORZ Launches VITOM(R) System for High-Resolution Visualization During Surgical Procedures
KARL STORZ Launches VITOM(R) System for High-Resolution Visualization During Surgical Procedures
HSMN NewsFeed - 24 May 2011
Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment
Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment
HSMN NewsFeed - 12 May 2011
Cancer Treatment Experts Detail Promising New Radiosurgical Techniques for Lung and Liver Cancer Patients
Cancer Treatment Experts Detail Promising New Radiosurgical Techniques for Lung and Liver Cancer Patients
HSMN NewsFeed - 6 May 2011
Varian Medical Systems Spotlights Advanced Radiosurgery Systems at ISRS Congress in Paris, May 8-12
Varian Medical Systems Spotlights Advanced Radiosurgery Systems at ISRS Congress in Paris, May 8-12
HSMN NewsFeed - 22 Apr 2011
Clinical Evidence Takes Center Stage at TomoTherapy Americas User Education Symposium
Clinical Evidence Takes Center Stage at TomoTherapy Americas User Education Symposium
HSMN NewsFeed - 18 Apr 2011
University of Virginia Installs First Two TomoTherapy(R) TomoHD(TM) Systems in U.S.
University of Virginia Installs First Two TomoTherapy(R) TomoHD(TM) Systems in U.S.
HSMN NewsFeed - 16 Mar 2011
First Varian High Dose Rate Brachytherapy Afterloader Supplied to Leading China Cancer Hospital
First Varian High Dose Rate Brachytherapy Afterloader Supplied to Leading China Cancer Hospital
HSMN NewsFeed - 19 Jan 2011
First Patients Complete Proton Therapy Treatment at CDH Proton Center, A ProCure Center
First Patients Complete Proton Therapy Treatment at CDH Proton Center, A ProCure Center
HSMN NewsFeed - 30 Nov 2010
Inspire Medical Systems Announces FDA approval for Pivotal Clinical Trial
Inspire Medical Systems Announces FDA approval for Pivotal Clinical Trial
HSMN NewsFeed - 29 Oct 2010
CyberKnife(R) VSI System Expands Treatment Applications and Significantly Reduces Treatment Times
CyberKnife(R) VSI System Expands Treatment Applications and Significantly Reduces Treatment Times
HSMN NewsFeed - 27 Oct 2010
University Radiotherapy Center of Antwerp to Install Industry's First TomoHD(TM) Treatment System
University Radiotherapy Center of Antwerp to Install Industry's First TomoHD(TM) Treatment System
HSMN NewsFeed - 19 Oct 2010
Devon Medical Products Receives FDA 510(k) Clearance for CircuFlow Sequential Compression Pump Models
Devon Medical Products Receives FDA 510(k) Clearance for CircuFlow Sequential Compression Pump Models
HSMN NewsFeed - 15 Oct 2010
Elekta to Highlight Latest Gamma Knife Surgery Innovations at Annual Neurosurgery Conference
Elekta to Highlight Latest Gamma Knife Surgery Innovations at Annual Neurosurgery Conference
HSMN NewsFeed - 13 Oct 2010
IsoRay's Revolutionary Internal Radiation Therapy for Lung Cancers is Focus of National Study
IsoRay's Revolutionary Internal Radiation Therapy for Lung Cancers is Focus of National Study
HSMN NewsFeed - 7 Oct 2010
IsoRay Announces World's First Cesium-131 Treatment for Metastasized Lung Cancer
IsoRay Announces World's First Cesium-131 Treatment for Metastasized Lung Cancer
HSMN NewsFeed - 16 Jul 2010
James Cook University Hospital Introduces Advanced TomoTherapy(R) Radiation Therapy Treatments
James Cook University Hospital Introduces Advanced TomoTherapy(R) Radiation Therapy Treatments
HSMN NewsFeed - 9 Jul 2010
BOTOX(R) Receives First Authorisation in UK as Preventative Treatment in Chronic Migraine
BOTOX(R) Receives First Authorisation in UK as Preventative Treatment in Chronic Migraine
HSMN NewsFeed - 22 Jun 2010
Brain Tunnelgenix Technologies Launched To Harness Discovery of Brain Temperature Tunnel(TM)
Brain Tunnelgenix Technologies Launched To Harness Discovery of Brain Temperature Tunnel(TM)
HSMN NewsFeed - 17 Jun 2010
Bayer and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
Bayer and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
HSMN NewsFeed - 30 Mar 2010
Germany's University Medical Center Mannheim Accelerates Cancer Care with Elekta's Monaco Planning Software
Germany's University Medical Center Mannheim Accelerates Cancer Care with Elekta's Monaco Planning Software
HSMN NewsFeed - 21 Jan 2010
IsoRay Announces World's First Cesium-131 Colon Cancer Treatment at Cornell Medical Center
IsoRay Announces World's First Cesium-131 Colon Cancer Treatment at Cornell Medical Center
HSMN NewsFeed - 12 Nov 2009
First Patients Complete Treatment at ProCure Proton Therapy Center in Oklahoma City
First Patients Complete Treatment at ProCure Proton Therapy Center in Oklahoma City
HSMN NewsFeed - 28 Oct 2009
Elekta Demonstrates Continued Leadership in Image Guidance at 2009 ASTRO Annual Meeting
Elekta Demonstrates Continued Leadership in Image Guidance at 2009 ASTRO Annual Meeting
HSMN NewsFeed - 23 Oct 2009
Elekta's Radiosurgery Solutions on Center Stage at 2009 Congress of Neurological Surgeons Annual Meeting
Elekta's Radiosurgery Solutions on Center Stage at 2009 Congress of Neurological Surgeons Annual Meeting
HSMN NewsFeed - 15 Oct 2009
Institute Curie Hospital Purchases Second TomoTherapy(R) Radiation Therapy System
Institute Curie Hospital Purchases Second TomoTherapy(R) Radiation Therapy System
HSMN NewsFeed - 21 Sep 2009
Moses Cone Regional Cancer Center Installs North Carolina's First TomoTherapy(R) Treatment System
Moses Cone Regional Cancer Center Installs North Carolina's First TomoTherapy(R) Treatment System
HSMN NewsFeed - 16 Sep 2009
Medtronic Launches New and Innovative Intraoperative Nerve Integrity Monitors for Surgeons
Medtronic Launches New and Innovative Intraoperative Nerve Integrity Monitors for Surgeons
HSMN NewsFeed - 29 Jul 2009
Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America
Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America
HSMN NewsFeed - 27 Jul 2009
Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharm
Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharm
HSMN NewsFeed - 23 Jul 2009
MuGard Data From UK Study Shows Prevention of Oral Mucositis in Head and Neck Cancer Patients
MuGard Data From UK Study Shows Prevention of Oral Mucositis in Head and Neck Cancer Patients
HSMN NewsFeed - 18 Jun 2009
Varian's RapidArc Radiotherapy Technology Enables Pioneering Cancer Treatments at Top Dutch Oncology Center
Varian's RapidArc Radiotherapy Technology Enables Pioneering Cancer Treatments at Top Dutch Oncology Center
HSMN NewsFeed - 1 Jun 2009
Laboratory Test May Predict Effectiveness of ERBITUX(R) for Individual Colorectal Cancer Patients
Laboratory Test May Predict Effectiveness of ERBITUX(R) for Individual Colorectal Cancer Patients
HSMN NewsFeed - 1 Jun 2009
UK's NICE Recommends Use of Erbitux for Metastatic Colorectal Cancer Patients
UK's NICE Recommends Use of Erbitux for Metastatic Colorectal Cancer Patients
HSMN NewsFeed - 8 May 2009
Lannett Company Receives FDA Approval for Pilocarpine HCI Tablets 7.5 mg Strength
Lannett Company Receives FDA Approval for Pilocarpine HCI Tablets 7.5 mg Strength
HSMN NewsFeed - 22 Apr 2009
RapidArc Radiotherapy Technology Enabling Fast, Accurate Treatments for Pennsylvania Cancer Patients
RapidArc Radiotherapy Technology Enabling Fast, Accurate Treatments for Pennsylvania Cancer Patients
HSMN NewsFeed - 20 Apr 2009
SpePharm Announces the European Launches of Two New Products: MuGard and Xerotin
SpePharm Announces the European Launches of Two New Products: MuGard and Xerotin
HSMN NewsFeed - 17 Mar 2009
Cardiorobotics Announces New CEO, PLSG Executive-in-Residence to Lead Company
Cardiorobotics Announces New CEO, PLSG Executive-in-Residence to Lead Company
HSMN NewsFeed - 16 Mar 2009
New Survey Reveals 'The Lipstick Effect' With Non-Invasive Facial Plastic Surgery Procedures
New Survey Reveals 'The Lipstick Effect' With Non-Invasive Facial Plastic Surgery Procedures
HSMN NewsFeed - 12 Mar 2009
Taiwan Treats Patient with New Cancer-Fighting Radiotherapy System from Elekta
Taiwan Treats Patient with New Cancer-Fighting Radiotherapy System from Elekta
HSMN NewsFeed - 26 Feb 2009
Inspire Medical Systems Completes First Implant of the Inspire II System to Treat Obstructive Sleep Apnea
Inspire Medical Systems Completes First Implant of the Inspire II System to Treat Obstructive Sleep Apnea
HSMN NewsFeed - 19 Feb 2009
Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea
Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea
HSMN NewsFeed - 26 Jan 2009
Sequenom Expands Molecular Diagnostics Portfolio with Acquisition of SensiGen
Sequenom Expands Molecular Diagnostics Portfolio with Acquisition of SensiGen
HSMN NewsFeed - 26 Jan 2009
Cleveland Clinic and Mubadala Healthcare Name CEO of Cleveland Clinic Abu Dhabi
Cleveland Clinic and Mubadala Healthcare Name CEO of Cleveland Clinic Abu Dhabi
HSMN NewsFeed - 7 Jan 2009
Siteman Cancer Center Adds Second TomoTherapy(R) Hi-Art(R) Treatment System
Siteman Cancer Center Adds Second TomoTherapy(R) Hi-Art(R) Treatment System
HSMN NewsFeed - 24 Nov 2008
NCCN Receives $1.5 Million Grant to Research Targeted Therapy in Bladder Cancer
NCCN Receives $1.5 Million Grant to Research Targeted Therapy in Bladder Cancer
HSMN NewsFeed - 19 Nov 2008
GenVec Announces Interim Survival Data in Pivotal Trial of TNFerade in Locally Advanced Pancreatic Cancer
GenVec Announces Interim Survival Data in Pivotal Trial of TNFerade in Locally Advanced Pancreatic Cancer
HSMN NewsFeed - 4 Nov 2008
Central California Doctors Now Using Fast RapidArc(TM) Radiotherapy Technology to Battle Cancer
Central California Doctors Now Using Fast RapidArc(TM) Radiotherapy Technology to Battle Cancer
HSMN NewsFeed - 29 Oct 2008
ImClone Announces ERBITUX(R) Commercial Launch in Canada for Advanced Colorectal Cancer
ImClone Announces ERBITUX(R) Commercial Launch in Canada for Advanced Colorectal Cancer
HSMN NewsFeed - 22 Sep 2008
OmniGuide Introduces The BeamPath Neuro(TM): A CO2 Laser Fiber for Brain And Spine Surgery
OmniGuide Introduces The BeamPath Neuro(TM): A CO2 Laser Fiber for Brain And Spine Surgery
HSMN NewsFeed - 22 Sep 2008
New Studies Confirm Safety, Effectiveness of Balloon Sinuplasty(TM) Technology for Chronic Sinusitis
New Studies Confirm Safety, Effectiveness of Balloon Sinuplasty(TM) Technology for Chronic Sinusitis
HSMN NewsFeed - 21 Sep 2008
Coapt Systems Launches FDA Cleared Novielle Voice (TM) for Restoration of Voice Loss
Coapt Systems Launches FDA Cleared Novielle Voice (TM) for Restoration of Voice Loss
HSMN NewsFeed - 19 Sep 2008
ERBITUX(R) Now Available in Japan for Use in Treating Patients with Advanced Colorectal Cancer
ERBITUX(R) Now Available in Japan for Use in Treating Patients with Advanced Colorectal Cancer
HSMN NewsFeed - 16 Sep 2008
ImClone Provides Update on Pivotal Phase 3 CRYSTAL Study in First-Line Metastatic Colorectal Cancer
ImClone Provides Update on Pivotal Phase 3 CRYSTAL Study in First-Line Metastatic Colorectal Cancer
HSMN NewsFeed - 2 Sep 2008
Introgen Receives Notice ADVEXIN(R) U.S. BLA Not Sufficiently Complete to File
Introgen Receives Notice ADVEXIN(R) U.S. BLA Not Sufficiently Complete to File
HSMN NewsFeed - 29 Aug 2008
ERBITUX(R) Phase 3 BMS-099 Lung Cancer Study Secondary Endpoint Update: Overall Survival Results Announced
ERBITUX(R) Phase 3 BMS-099 Lung Cancer Study Secondary Endpoint Update: Overall Survival Results Announced
HSMN NewsFeed - 22 Aug 2008
CMS, Inc., an Elekta Company, Receives FDA 510(k) Clearance for Atlas-Based Autosegmentation Software
CMS, Inc., an Elekta Company, Receives FDA 510(k) Clearance for Atlas-Based Autosegmentation Software
HSMN NewsFeed - 31 Jul 2008
Bristol-Myers Squibb Proposes to Acquire ImClone Systems for $60.00 Per Share in Cash
Bristol-Myers Squibb Proposes to Acquire ImClone Systems for $60.00 Per Share in Cash
HSMN NewsFeed - 29 Jul 2008
Advaxis Incorporated Receives List of Questions from the U.S. Food and Drug Administration
Advaxis Incorporated Receives List of Questions from the U.S. Food and Drug Administration
HSMN NewsFeed - 25 Jul 2008
Cochlear Announces Milestone in Hearing Restoration With 120,000 Nucleus(R) Cochlear Implants
Cochlear Announces Milestone in Hearing Restoration With 120,000 Nucleus(R) Cochlear Implants
HSMN NewsFeed - 16 Jul 2008
ERBITUX(R) (Cetuximab) Receives Approval in Japan for Use in Advanced Colorectal Cancer
ERBITUX(R) (Cetuximab) Receives Approval in Japan for Use in Advanced Colorectal Cancer
HSMN NewsFeed - 3 Jul 2008
Seven Major U.S. Cancer Institutions Order Hyperthermia Systems from BSD Medical
Seven Major U.S. Cancer Institutions Order Hyperthermia Systems from BSD Medical
HSMN NewsFeed - 30 Jun 2008
Introgen Submits ADVEXIN(R) Regulatory Applications in the U.S. and Europe
Introgen Submits ADVEXIN(R) Regulatory Applications in the U.S. and Europe
HSMN NewsFeed - 28 May 2008
ADVEXIN(R) Improves Survival in Recurrent, Refractory Head and Neck Cancer Patients
ADVEXIN(R) Improves Survival in Recurrent, Refractory Head and Neck Cancer Patients
HSMN NewsFeed - 26 May 2008
Elekta: Leksell Gamma Knife(R) Perfexion(TM) Receives Regulatory Approval in Japan
Elekta: Leksell Gamma Knife(R) Perfexion(TM) Receives Regulatory Approval in Japan
HSMN NewsFeed - 23 Apr 2008
Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability
Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability
HSMN NewsFeed - 14 Apr 2008
Artes Medical Reports Over Seven Thousand Patients Treated with ArteFill since February 2007 Product Launch
Artes Medical Reports Over Seven Thousand Patients Treated with ArteFill since February 2007 Product Launch
HSMN NewsFeed - 9 Apr 2008
Abraxis BioScience Announces Approval to Market ABRAXANE for Metastatic Breast Cancer in Korea
Abraxis BioScience Announces Approval to Market ABRAXANE for Metastatic Breast Cancer in Korea
HSMN NewsFeed - 26 Mar 2008
CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide
CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide
HSMN NewsFeed - 13 Mar 2008
Hawthorn Pharmaceuticals, Inc. Receives FDA Approval on Granisol(TM) Oral Solution
Hawthorn Pharmaceuticals, Inc. Receives FDA Approval on Granisol(TM) Oral Solution
HSMN NewsFeed - 7 Mar 2008
Amgen Announces Update to U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
Amgen Announces Update to U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
HSMN NewsFeed - 25 Feb 2008
Marillion Pharmaceuticals and Cytokine PharmaSciences Announce License Agreement for Xerostomia Treatment
Marillion Pharmaceuticals and Cytokine PharmaSciences Announce License Agreement for Xerostomia Treatment
HSMN NewsFeed - 7 Feb 2008
Elekta Users First to Treat Patients with Volumetric Intensity Modulated Arc Therapy (VMAT)
Elekta Users First to Treat Patients with Volumetric Intensity Modulated Arc Therapy (VMAT)
HSMN NewsFeed - 4 Feb 2008
Amgen and Takeda Announce Exclusive Collaboration in Japan on up to 13 Amgen Clinical Candidates
Amgen and Takeda Announce Exclusive Collaboration in Japan on up to 13 Amgen Clinical Candidates
HSMN NewsFeed - 22 Jan 2008
Abraxis Receives Approval from EU Commission to Market ABRAXANE for Metastatic Breast Cancer in Europe
Abraxis Receives Approval from EU Commission to Market ABRAXANE for Metastatic Breast Cancer in Europe
HSMN NewsFeed - 2 Jan 2008
Varian Medical Systems Receives FDA 510(k) Clearance for RapidArc(TM) Radiotherapy Technology
Varian Medical Systems Receives FDA 510(k) Clearance for RapidArc(TM) Radiotherapy Technology
HSMN NewsFeed - 7 Dec 2007
Amgen in Discussions with FDA to Update U.S. Prescribing Information for ESAs
Amgen in Discussions with FDA to Update U.S. Prescribing Information for ESAs
HSMN NewsFeed - 5 Dec 2007
Vectibix(R) Approved in the European Union for the Treatment of Metastatic Colorectal Cancer
Vectibix(R) Approved in the European Union for the Treatment of Metastatic Colorectal Cancer
HSMN NewsFeed - 27 Nov 2007
Introgen's ADVEXIN Advances as Marketing Authorization Application is Accepted for Review in Europe
Introgen's ADVEXIN Advances as Marketing Authorization Application is Accepted for Review in Europe
HSMN NewsFeed - 27 Nov 2007
Gendux Announces Acceptance of Its ADVEXIN Marketing Authorization Application for Review by the EMEA
Gendux Announces Acceptance of Its ADVEXIN Marketing Authorization Application for Review by the EMEA
HSMN NewsFeed - 14 Nov 2007
New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
HSMN NewsFeed - 13 Nov 2007
Introgen and Gendux Submit First Marketing Authorization Application for ADVEXIN
Introgen and Gendux Submit First Marketing Authorization Application for ADVEXIN
HSMN NewsFeed - 8 Nov 2007
Ortho Biotech to Submit Official Request for Reconsideration to CMS Regarding ESA Coverage Policy
Ortho Biotech to Submit Official Request for Reconsideration to CMS Regarding ESA Coverage Policy
HSMN NewsFeed - 29 Oct 2007
Elekta Announces Elekta Infinity - a New System for Faster and More Precise Treatment of Cancer Tumors
Elekta Announces Elekta Infinity - a New System for Faster and More Precise Treatment of Cancer Tumors
HSMN NewsFeed - 29 Oct 2007
St. Joseph Hospital Selects IntraOp Medical's Mobetron to Deliver Advanced Cancer Treatment
St. Joseph Hospital Selects IntraOp Medical's Mobetron to Deliver Advanced Cancer Treatment
HSMN NewsFeed - 8 Oct 2007
Cyclacel Pharmaceuticals Acquires Specialty Pharmaceutical Business Focused on the Oncology Market
Cyclacel Pharmaceuticals Acquires Specialty Pharmaceutical Business Focused on the Oncology Market
HSMN NewsFeed - 4 Oct 2007
Declan P. Doogan, M.D. Joins IRX Therapeutics as Advisor on Global Product Development
Declan P. Doogan, M.D. Joins IRX Therapeutics as Advisor on Global Product Development
HSMN NewsFeed - 27 Sep 2007
Amgen Receives Proposal for Amending EU Prescribing Information for Aranesp(R)
Amgen Receives Proposal for Amending EU Prescribing Information for Aranesp(R)
HSMN NewsFeed - 25 Sep 2007
ProCure Treatment Centers Teams with Forte Automation Systems to Enhance Proton Therapy for Cancer Patients
ProCure Treatment Centers Teams with Forte Automation Systems to Enhance Proton Therapy for Cancer Patients
HSMN NewsFeed - 25 Sep 2007
Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
HSMN NewsFeed - 18 Sep 2007
New U.S. Multi-Center Clinical Study Affirms Efficacy and Benefit of Restore Medical's Pillar(R) Procedure
New U.S. Multi-Center Clinical Study Affirms Efficacy and Benefit of Restore Medical's Pillar(R) Procedure
HSMN NewsFeed - 17 Sep 2007
DORO (R) CereTom (R) Allows On-Demand CT Scanning with Real-Time Diagnostics in Operating Room
DORO (R) CereTom (R) Allows On-Demand CT Scanning with Real-Time Diagnostics in Operating Room
HSMN NewsFeed - 11 Sep 2007
Amgen to Review Benefits, Risks of ESA Therapy in Chronic Renal Failure Patients at FDA Advisory Committee
Amgen to Review Benefits, Risks of ESA Therapy in Chronic Renal Failure Patients at FDA Advisory Committee
HSMN NewsFeed - 11 Sep 2007
ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
HSMN NewsFeed - 10 Sep 2007
ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property
ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property
HSMN NewsFeed - 28 Aug 2007
World Champion Indianapolis Colts Adopt Portable CT Technology to Diagnose Head Trauma
World Champion Indianapolis Colts Adopt Portable CT Technology to Diagnose Head Trauma
HSMN NewsFeed - 2 Aug 2007
OncoLogics, Inc., Signs Deal to Bring Proton Beam Radiation Therapy to Louisana
OncoLogics, Inc., Signs Deal to Bring Proton Beam Radiation Therapy to Louisana
HSMN NewsFeed - 27 Jul 2007
Bristol-Myers Squibb and Imclone Systems Significantly Expand ERBITUX Clinical Development Program
Bristol-Myers Squibb and Imclone Systems Significantly Expand ERBITUX Clinical Development Program
HSMN NewsFeed - 16 Jul 2007
Study Confirms Balloon Sinuplasty(TM) Technology is Safe and Effective for Chronic Sinusitis Patients
Study Confirms Balloon Sinuplasty(TM) Technology is Safe and Effective for Chronic Sinusitis Patients
HSMN NewsFeed - 12 Jul 2007
Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung Cancer
Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung Cancer
HSMN NewsFeed - 10 Jul 2007
OmniGuide(R) Launches the OtoBeam Flexible CO2 Laser Fiber Product Line for Otology
OmniGuide(R) Launches the OtoBeam Flexible CO2 Laser Fiber Product Line for Otology
HSMN NewsFeed - 27 Jun 2007
YM BioSciences Receives FDA Clearance for an IND for its Fentanyl-Based Pain Product AeroLEF(TM)
YM BioSciences Receives FDA Clearance for an IND for its Fentanyl-Based Pain Product AeroLEF(TM)
HSMN NewsFeed - 12 Jun 2007
CEL-SCI Receives US FDA Orphan Drug Designation for Its Cancer Drug Multikine(R)
CEL-SCI Receives US FDA Orphan Drug Designation for Its Cancer Drug Multikine(R)
HSMN NewsFeed - 5 Jun 2007
Extensive Clinical Data on ERBITUX(R) Presented at the 2007 ASCO Annual Meeting
Extensive Clinical Data on ERBITUX(R) Presented at the 2007 ASCO Annual Meeting
HSMN NewsFeed - 5 Jun 2007
Inovio Biomedical Stops Enrollment of Phase III Clinical Trials for Head & Neck Cancer
Inovio Biomedical Stops Enrollment of Phase III Clinical Trials for Head & Neck Cancer
HSMN NewsFeed - 4 Jun 2007
YM BioSciences Cleared to Initiate Clinical trial of Nimotuzumab in Colorectal Cancer
YM BioSciences Cleared to Initiate Clinical trial of Nimotuzumab in Colorectal Cancer
HSMN NewsFeed - 22 May 2007
Aspire Medical Announces First Implant in US and Start of Clinical Trial to Treat Sleep Apnea
Aspire Medical Announces First Implant in US and Start of Clinical Trial to Treat Sleep Apnea
HSMN NewsFeed - 18 May 2007
BSD Medical's Hyperthermia Therapy Now Offered at Cancer Treatment Centers of America
BSD Medical's Hyperthermia Therapy Now Offered at Cancer Treatment Centers of America
HSMN NewsFeed - 9 May 2007
Poniard Pharmaceuticals Appoints Ronald A. Martell President and Chief Operating Officer
Poniard Pharmaceuticals Appoints Ronald A. Martell President and Chief Operating Officer
HSMN NewsFeed - 30 Apr 2007
NeuroLogica Launches CereTom OTOscan CT Scanner for The Otolaryngology Market
NeuroLogica Launches CereTom OTOscan CT Scanner for The Otolaryngology Market
HSMN NewsFeed - 30 Apr 2007
Washington Hospital Installs First Leksell Gamma Knife(R) Perfexion(TM) in United States
Washington Hospital Installs First Leksell Gamma Knife(R) Perfexion(TM) in United States
HSMN NewsFeed - 19 Apr 2007
Aranesp(R) ``145 Study'' Shows No Difference in Survival in Patients with Small-Cell Lung Cancer
Aranesp(R) ``145 Study'' Shows No Difference in Survival in Patients with Small-Cell Lung Cancer
HSMN NewsFeed - 16 Apr 2007
YM BioSciences' partner Daiichi Sankyo receives clearance for initial clinical trial in Japan
YM BioSciences' partner Daiichi Sankyo receives clearance for initial clinical trial in Japan
HSMN NewsFeed - 10 Apr 2007
Data Available from ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
Data Available from ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
HSMN NewsFeed - 10 Apr 2007
Leading China Cancer Center Offers Advanced Radiotherapy Treatments Using Varian's On-Board Imager
Leading China Cancer Center Offers Advanced Radiotherapy Treatments Using Varian's On-Board Imager
HSMN NewsFeed - 4 Apr 2007
Survival Data Available From ERBITUX(R) Study in First-Line Treatment of Advanced Head and Neck Cancer
Survival Data Available From ERBITUX(R) Study in First-Line Treatment of Advanced Head and Neck Cancer
HSMN NewsFeed - 9 Mar 2007
Ortho Biotech Revises Prescribing Information for PROCRIT(R) (Epoetin alfa)
Ortho Biotech Revises Prescribing Information for PROCRIT(R) (Epoetin alfa)
HSMN NewsFeed - 9 Mar 2007
Amgen Announces Update To U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
Amgen Announces Update To U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
HSMN NewsFeed - 6 Mar 2007
New Hybrid(TM) CPAP Mask Emerging as a Strong Alternative to C-Flex/EPR and Bi-level Machines
New Hybrid(TM) CPAP Mask Emerging as a Strong Alternative to C-Flex/EPR and Bi-level Machines
Additional items found! 291
Members Archive contains
291 additional stories matching:
head and neck
(Password required)
head and neck
(Password required)
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!